Altogether, these findings highlight the complex and variant-specific effects of tau on mitochondrial calcium homeostasis and suggest that targeting tau-mediated MAM dysfunction could offer a promising neuroprotective strategy in AD and related tauopathies. This evidence concerns the gene MAPT and tauopathy.